ARTICLE | Company News
EC approves Raptiva
September 23, 2004 7:00 AM UTC
The EC granted marketing approval to Serono (SWX:SEO; SRA) for Raptiva efalizumab to treat moderate to severe chronic plaque psoriasis. SEO has exclusive European rights to the humanized monoclonal an...